Time to act on trials
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Number 52
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we sit back and wait... [ more ]
Vincenzo Valentini: putting knowledge to work
Patients are being let down by a failure to integrate the knowledge we have to get the best possible results for each individual patient and for cancer patients as a whole. Vincenzo Valentini, the ESTRO [more]
The reoperation lottery
The odds that a woman will be told she needs a reoperation after conservative breast surgery vary between treatment centres, prompting calls for international guidelines and greater oversight of surgeons. For many women with [more]
Stop Cancer Now!
Cancer poses a rising threat to global health as well as the world economy. International experts have agreed on a strategy that can meet the challenge. They are now calling on world leaders to wake [more]
Me and my cancer
Journalists who write about their own cancer journeys are able to convey important insights in a language that people understand and are eager to read It is not surprising that a lot of journalists [more]
Survivor services: supporting patients living with and beyond cancer
Helping patients make the best of their lives after treatment starts with thinking ahead before treatment and tailoring support for as long as it is needed. A leader in the field talks about key issues [more]
Taking the isolation out of isolation
The isolation that is essential to the physical health of people undergoing stem cell transplantation can be terrible for their mental health at a time of great stress. Patients are giving the thumbs up to [more]
Diabetes risk after radiation not out of the woods
A retrospective cohort study has shown that pancreatic radiation is a risk factor for diabetes in survivors of paediatric cancer. This validates and refines prior epidemiological observations of diabetes after radiation to the abdomen and [more]
My World
Ramon Salazar is head of translational research at the Institut Català d’Oncologia near Barcelona. He leads the Early Clinical Research Unit and is in charge of the colorectal and neuroendocrine tumour clinics. He is a [more]